Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_1382_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Contents
- •1. Thyroid Embryology, Anatomy, and Physiology: A Review for the Surgeon
- •2. The Assessment of Thyroid Nodules
- •3. Thyroid: Fine-Needle Aspiration Biopsy
- •4. Thyroid Imaging
- •5. Multinodular Goiter
- •6. Thyrotoxicosis and Thyroiditis: Causes, Investigation, and Management
- •7. Molecular Biology of Thyroid Cancer
- •8. Well-Differentiated Thyroid Cancer: An Overview and the Chernobyl Effect
- •9. Poorly Differentiated and Undifferentiated Thyroid Cancer
- •10. Postoperative Management of Well-Differentiated Thyroid Cancer
- •11. Medullary Thyroid Cancer
- •12. Technique of Thyroidectomy
- •13. Lymph Node Dissection in Thyroid Cancer
- •14. Management of the Laryngeal Nerves and Voice
- •15. Embryology, Anatomy, and Physiology of the Parathyroid Glands
- •16. Presentation and Diagnosis of Primary Hyperparathyroidism
- •17. Parathyroid Localization and Imaging
- •18. Intraoperative PTH Monitoring
- •19. Focused Parathyroidectomy
- •20. Parathyroid: Bilateral Neck Exploration
- •21. Reoperative Parathyroid Surgery
- •22. Management of Secondary and Tertiary Hyperparathyroidism
- •23. Parathyroid Carcinoma
- •24. Adrenal Embryology, Anatomy, and Physiology
- •25. Adrenal Imaging
- •26. Adrenal Venous Sampling
- •27. Primary Hyperaldosteronism
- •29. Pheochromocytoma and Paraganglioma
- •30. Adrenocortical Carcinoma
- •31. Incidentaloma
- •32. Adrenal Metastases and Rare Adrenal Tumors
- •33. Technique of Open and Laparoscopic Adrenalectomy
- •34. Laparoscopic Retroperitoneal Adrenalectomy
- •35. Pancreas: Embryology, Anatomy, and Physiology
- •36. Pancreatic Imaging: The Value for Surgery of Neuroendocrine Pancreatic Tumors

120
ENDOCRINE SURGERY
58. Demidchik YE, Saenko VA, Yamashita S. Childhood
thyroid cancer in Belarus, Russia, and Ukraine after
Chernobyl and at present. Arq Bras Endocrinol Metabol.
2007; 51(5):748–62.
59. Nikiforov YE, Gnepp DR. Pathomorphology of thyroid
gland lesions associated with radiation exposure: the
Chernobyl experience and review of the literature. Adv
Anat Pathol. 1999; 6(2):78–91.
60. Williams ED, Abrosimov A, Bogdanova T, et al. Thyroid
carcinoma after Chernobyl latent period, morphology
and aggressiveness. Br J Cancer. 2004; 90(11):2219–24.
61. Bogdanova TI, Zurnadzhy LY, Greenebaum E, et al. A
cohort study of thyroid cancer and other thyroid diseases after the Chornobylaccident: pathology analysisof
thyroid cancer cases in Ukraine detected during the first
screening (1998–2000). Cancer. 2006; 107(11):2559–66.
62. Ito T, Seyama T, Iwamoto KS, et al. Activated RET
oncogene in thyroid cancers of children from areas
contaminated by Chernobyl accident. Lancet. 1994;
344(8917):259.
63. Fugazzola L, Pilotti S, Pinchera A, et al. Oncogenic
rearrangements of the RET proto-oncogene in papillary
thyroid carcinomas from children exposed to the Chernobyl nuclear accident. Cancer Res. 1995; 55(23):
5617–20.
64. Nikiforov YE, Rowland JM, Bove KE, et al. Distinct
pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid
papillary carcinomas in children. Cancer Res. 1997;
57(9):1690–4.
65. Smida J, Salassidis K, Hieber L, et al. Distinct frequency
of ret rearrangements in papillary thyroid carcinomas of
children and adults from Belarus. Int J Cancer. 1999;
80(1):32–8.
66. Thomas GA, Bunnell H, CookHA, et al.High prevalenceof
RET/PTC rearrangements in Ukrainian and Belarussian
post-Chernobyl thyroid papillary carcinomas: a strong
correlation between RET/PTC3 and the solid-follicular
variant. J Clin Endocrinol Metab. 1999; 84(11):4232–8.
67. Bongarzone I, Vigneri P, Mariani L, et al. RET/NTRK1
rearrangements in thyroid gland tumors of the papillary
carcinoma family: correlation with clinicopathological
features. Clin Cancer Res. 1998; 4(1):223–8.
68. Learoyd DL, Messina M, Zedenius J, et al. RET/PTC and
RET tyrosine kinase expression in adult papillary thyroid carcinomas. J Clin Endocrinol Metab. 1998; 83(10):
3631–5.
69. Ciampi R, Nikiforov YE. RET/PTC rearrangements and
BRAF mutations in thyroid tumorigenesis. Endocrinology. 2007; 148(3):936–41.
70. Tallini G, Asa SL. RET oncogene activation in papillary
thyroid carcinoma. Adv Anat Pathol. 2001; 8(6):345–54.
71. Rabes HM, Demidchik EP, Sidorow JD, et al. Pattern of
radiation-induced RET and NTRK1 rearrangements in
191 post-chernobyl papillary thyroid carcinomas: biological, phenotypic, and clinical implications. Clin Cancer Res. 2000; 6(3):1093–103.
72. Robbins J, Dunn JT, Bouville A, et al. Iodine nutrition
and the risk from radioactive iodine: a workshop report
in the chernobyl long-term follow-up study. Thyroid.
2001; 11(5):487–91.
73. Mityukova TA, AstakhovaLN, Asenchyk LD, et al. Urinary iodine excretion in Belarus children. Eur J Endocrinol. 1995; 133(2):216–7.
74. Ashizawa K, Shibata Y, Yamashita S, et al. Prevalence of
goiter and urinary iodine excretion levels in children
around Chernobyl. J Clin Endocrinol Metab. 1997;
82(10):3430–3.
75. Tronko M, Kravchenko V, Fink D, etal. Iodineexcretion
in regions of Ukraine affected by the Chornobyl Accident: experience of the Ukrainian-American cohort
study of thyroid cancer and other thyroid diseases.
Thyroid. 2005; 15(11):1291–7.
76. Shakhtarin VV, Tsyb AF, Stepanenko VF, et al. Iodine
deficiency, radiation dose, and the risk ofthyroid cancer
among children and adolescents in the Bryansk region
of Russia following the Chernobyl power station accident. Int J Epidemiol. 2003; 32(4):584–91.

9
Poorly Differentiated and Undifferentiated Thyroid Cancer
Anthony J. Chambers and Janice L. Pasieka
Introduction
Thyroid carcinoma in its differentiated form is
associated with an excellent long-term prognosis, with surgical resection and the use of
radioactive iodine providing effective treatment
and cure in a high proportion of patients. In
contrast to well-differentiated thyroid cancer
(WDTC), poorly differentiated forms of thyroid
cancer exist which are associated with a more
aggressive clinical course and a correspondingly less favorable prognosis. At the extreme
of the spectrum of differentiation of thyroid
cancers, undifferentiated (anaplastic) thyroid
cancer (UTC) is one of the most biologically
aggressive and lethal of human malignancies,
displaying rapid invasive growth and early
metastatic dissemination. It is recognized that
some thyroid cancers display a degree of differentiation and biological behavior which is
intermediate between WDTC and UTC in this
spectrum, and this group has been referred to
as poorly differentiated thyroid cancer (PDTC).
Poorly Differentiated Thyroid
Cancer
In contrast to more differentiated forms of thyroid cancer, PDTC possesses a tendency for local
invasion beyond the capsule of the thyroid,
recurrence after surgical resection and metastatic
dissemination, and as such is associated with a
worse prognosis. PDTC displays a degree of differentiation on histology which lies on the spectrum between the well-preserved differentiation
of WDTC and the anaplastic features of UTC. In
PDTC, the characteristic follicular or papillary
appearance of WDTC is not present, instead
less differentiated growth patterns are observed.
The classification of thyroid cancer as PDTC
remains poorly defined. The most recent World
Health Organization classification of thyroid
tumors does not provide a criteria for categorization of PDTC, yet biologically there appears to
be thyroid tumors that behave more aggressively
than WDTC [1]. Until recently, there has not
been agreement among pathologists in the classification of PDTC. A recently published diagnostic criteria for PDTC based on tumor histology has been proposed after review of 83 cases at
a consensus meeting of thyroid pathologists in
Turin, Italy [2]. In this classification, variants of
follicular and papillary thyroid cancer which display more aggressive behaviors such as the
columnar cell, tall cell, solid, and diffuse-sclerosing variants of papillary thyroid cancer are not
considered PDTC [3]. PDTC is characterized by
(1) the presence of an insular, solid, or trabecular
patternofgrowthonhistology,(2)theabsenceof
nuclear features of papillary carcinoma, and (3)
the presence of one or more of the following
features: convoluted nuclei, three or more
mitoses per 10 high-power fields or foci of
tumor necrosis [2]. PDTC with a predominantly
J.G.H. Hubbard et al. (eds.), Endocrine Surgery, Springer Specialist Surgery Series,
DOI 10.1007/978-1-84628-881-4_9, Ó Springer-Verlag London Limited 2009
121

122
ENDOCRINE SURGERY
insular growth pattern on histology has been
referred to as insular carcinoma and represents
a distinct variant of thyroid carcinoma which
cannot be clearly related to follicular or papillary
carcinoma, with an aggressive behavior and prognosis which lie between those of WDTC and anaplastic cancers [4].
Insular Carcinoma
Insular carcinoma is an aggressive form of thyroid malignancy and accounts for 3–6% of cases
of thyroid carcinoma [5–7]. It occurs more commonly in females with a female to male ratio of
2:1 [4, 6, 8]. The meanage ofonset is 51–57 years,
with a range from 11 to 79 [4, 6–8]. Most patients
with insular carcinoma present with symptoms
of an enlarging mass, with 8% presenting with
symptoms related to metastatic disease [4, 7]. In
27–60% of cases, the tumor develops within a
preexisting goiter [6, 7]. Insular carcinomas
have generally reached a large size by the time
of presentation, with a mean of 5–6 cm [6, 8, 9].
Extrathyroidal invasion of the cancer into adjacent soft tissues and anatomical structures
occurs in 69% at the time of presentation, including the trachea or larynx in 15% of cases [10].
Spread to regionallymph nodes may be apparent
in 20–44% of patients at presentation and distant
metastases in 8–67% [4, 9–11]. Distant metastatic
spread occurs in 32–85% of patients, most frequentlyto the lung (61%) orbony skeleton (50%)
and less commonly to the liver (11%) [4, 7–11].
Fine needle aspirates from insular lesions
are diagnostic in most cases, with features typical of high-grade follicular neoplasms [12].
Aspirates are generally hypercellular with
minimal colloid, and cytopathology characteristically demonstrates numerous round to oval
pleomorphic follicular cells with scant eosinophilic cytoplasm and uniform nuclei, arranged
in small nests or as individual cells [12–14].
Insular carcinomas are solid tumors with a
pale coloration, and regions of hemorrhage and
necrosis within the tumor substance are commonly present. The histological appearance of
these tumors was first characterized by Carcangiu, who described tumor cells forming large,
well-defined nests, separated from surrounding
tissue by prominent clefts [4]. Tumor cells are
uniform, small, and rounded in appearance with
a scant eosinophilic granular cytoplasm (Fig. 9.1)
[9]. In contrast to UTC, cells display minimal
a
b
Fig. 9.1. (A) Photomicrograph of poorly differentiated thyroid
cancer with an insular growth pattern. Insulae contain relatively
uniform cuboidal cells with scant eosinophilic cytoplasm and
minimal pleomorphism. Nuclear features of papillary thyroid
cancer are absent. (20 magnification). (B) Poorly differentiated
thyroid cancer with solid and trabecular growth patterns.
A mitotic figure is present (arrow)(20 magnification).
pleomorphism, and tumor giant cells and multinucleatedcells are not identified. The tumor cells
have nuclei which can appear optically clear and
resemble those of papillary cancer, but nuclear
overlapping and other features of papillary cancer are not present. Cells can be arranged in
characteristic nests, in solid sheets of cells or in
a trabecular pattern, and can form small follicles
[4, 6, 9, 15]. The tumors can display a predominantly insular growth pattern or can contain
mostly trabecular or solid arrangements [9, 16].
Mitoses are identified frequently throughout
the tumor and occur to a variable extent. Areas
of necrosis are commonly present and invasion
of vascular structures is seen in 44–100% of

123
POORLY DIFFERENTIATED AND UNDIFFERENTIATED THYROID CANCER
tumours [4, 6, 9, 15]. Immunohistochemistry is
useful in the characterization of these tumors.
Staining for thyroglobulin is positive in almost
all cases confirming the follicular cell origin of
the tumors [4, 9, 15]. Stains for keratin are positive in 75% of cases, and negative staining for
calcitonin enables differentiation of these tumors
from medullary thyroid carcinoma.
Pathogenesis of Poorly
Differentiated Thyroid Cancer
Regions of WDTC are present in the resection
specimens of insular carcinoma and other
PDTC in 59% of cases, and PDTC can be found
in association with 13% of UTC, suggesting that
PDTC represents a step in the progression and
transformation from WDTC to UTC. Genetic
studies of WDTC, PDTC, and UTC using comparative genomic hybridization have shown a
progressive accumulation of chromosomal
abnormalities from differentiated to undifferentiated forms [17]. Tissue microarray identification of four candidate gene mutations found a
similar progressive increase in mutations
occurring among WDTC, PDTC, and UTC providing further evidence that PDTC may represent an intermediate stage in dedifferentiation
[18]. The tumor suppressor gene p53 may be
involved in this process, as mutations are present in 32% of UTC and 12% of PDTC and rarely
occur in WDTC [18].
Management and Outcomes
of Poorly Differentiated
Thyroid Cancers
PDTC is uncommon in comparison to WDTC,
and fewer studies exist which examine the role
of surgical and adjuvant treatments of this disease. In contrast to WDTC, multimodality treatment with a combination of aggressive surgical
resection or debulking, radioactive iodine, and
external beam radiotherapy may be indicated to
achieve local control of the tumor [3]. In the
initial description of insular PDTC from a series
of 25 patients at the University of Florence,
surgical resection was performed in 24 cases of
which 20 were total or near-total thyroidectomies. This was combined with formal lymph
node dissection in seven cases, and external
beam radiotherapy was given postoperatively in
two cases. The mortality during the 8-year period
of follow up of these patients was 56%, with 84%
of cases developing locoregional recurrence or
disseminated disease. Recurrent disease in the
neck developed in 50% of patients who underwent thyroid lobectomy and in 42% of those who
underwent total thyroidectomy. Surgical resection by total or near-total thyroidectomy was
performed for 20 of 22 patients managed at the
Queen Mary Hospital in Hong Kong, and this
was combined with postoperative external beam
radiotherapy in eight cases [7]. Forty-two percent of patients survived greater than 10 years,
with disseminated metastatic disease developing
in 32%. Postoperative radiotherapy to improve
locoregional control has been recommended for
PDTC due to the high incidence of extrathyroidal
invasion, regional lymph node involvement, and
locoregional recurrence, particularlywhen resection has been macroscopically incomplete [3].
The actual benefit of external beam radiotherapy
in this setting is not known. In a study which
collectively reviewed the outcomes after treatment of previously published case series of insular PDTC, external beam radiotherapy was not
associated with an improvement in survival [8].
Given the high rate of local recurrence of PDTC,
however, it is reasonable to recommend postoperative external beam radiotherapy to maximize the chance of maintaining locoregional
control.
In contrast to UTC, which is rarely capable of
organifying iodine, uptake of
shown in more than 80% of PDTC and can be
effective in the treatment of local and disseminated disease [9, 19]. Although the response to
treatment of PDTC is poor compared to that of
WDTC, [6, 10] and treatment with radioactive
iodine was not associated with a survival advantage in two studies examining its role,
should be given to all patients with PDTC postoperatively because of the potential benefit and
lack of morbidity associated with this treatment
[3, 6, 8, 10]. In patients with tumors capable of
taking up iodine, whole-body scanning with
radioactive iodine can detect distant metastases.
Positron emission tomography with F18-fluorodeoxyglucose in patients with PDTC shows
uptake of the isotope in most cases and has
been used in the assessment of metastatic disease where tumor does not take up radioactive
iodine [20, 21].
131
I has been
131
I

124
ENDOCRINE SURGERY
In a large study of 183 cases of PDTC demonstrating an insular histology from the University
of Turin, a 5-year survival rate of 85% and
10-year survival of 67% was found [6]. Patients
greater than 45 years, the presence of necrosis
within the tumor, and higher numbers of
mitoses on histology were associated with a
worse prognosis. In the review combining the
results of previously published series of insular
PDTC, a 5-year survival of 72% and 10-year
survival of 52% were calculated [8]. Patients
older than 45 years and the presence of disseminated disease were associated with a higher
mortality in this study. Although supported by
level IV evidence only, aggressive surgical resection followed by
therapy for locoregional control appears to offer
the best chance of long-term survival for
patients with PDTC [3]. Systemic therapy
should also be considered within a study protocol because of the high likelihood of developing
disseminated metastatic disease.
131
I and external beam radio-
Undifferentiated (Anaplastic)
Thyroid Cancer
Undifferentiated (anaplastic) thyroid carcinoma is one of the most aggressive forms of
cancer seen in humans and fortunately represents only a small proportion of malignancies of
the thyroid gland. In sharp contrast to differentiated forms of thyroid cancer, anaplastic cancer
is characterized by aggressive local invasion and
early widespread metastatic dissemination, with
few patients surviving longer than 12 months
after presentation [22]. Local treatment with
surgical resection and external beam radiotherapy and single modality systemic chemotherapy
have limited roles in the management of UTC in
achieving palliation and prolonging survival.
The rarity of this disease has made it difficult
to study.
Clinical Features
UTC is an uncommon form of thyroid malignancy, accounting for only 1.7% of all thyroid
cancers recorded in the National Cancer Database of the American Cancer Society [23]. Studies from the large Surveillance, Epidemiology
and End Results Program (SEER) cancer
registry database of the National Cancer Institute showed no change in the incidence of UTC
from 1973–2002 [24]. UTC occurs most commonly in the elderly, with a peak incidence seen
in the seventh decade of life and a mean age of
presentation between 65 and 75 years [22,
25–28]. It is rarely seen in patients younger
than 40 years, and the mean age at presentation
is considerably higher than that seen in differentiated thyroid cancers. Females are overrepresented in most series of UTC, with reported
female to male ratios of 1.5:1 to 2:1 [22, 25–28].
Few risk factors have been associated with UTC.
A higher incidence in iodine-deficient areas and
regions of endemic goiter has been found in
some studies but not in others [29–31]. A history of irradiation of the head and neck may be
seen in up to 10% of patients and a causal
relationship has been suggested [27, 32–37].
UTC occurring following radiation exposures
tend to occur at a younger age than is normally
observed, and has a mean latency period of
27 years postexposure [34].
Most patients with UTC present with symptoms related to a rapidly enlarging neck mass,
accounting for 70–99% of presentations [22, 27,
28, 37–39]. In 10–29% of patients, enlargement
of a previously stable goiter is the presenting
feature [27, 37, 38, 40, 41]. A smaller proportion
of patients may present with symptoms related
to distant metastases (3–10%) or with systemic
features such as weight loss [22, 27]. Symptoms
had been present for a mean duration of
1 month prior to presentation in some studies
[28, 38]. The size of the mass and its rapid
growth are frequently associated with symptoms of compression of the airway, upper aerodigestive tract or vascular structures with
stridor, difficulty in breathing, dysphagia, evidence of superior vena cava obstruction or
voice change noted in up to 51% of patients at
presentation [27, 28, 37, 38]. Voice change when
present may be due to the effects of local compression or to involvement of the recurrent
laryngeal nerve by direct tumor invasion.
Acute upper airway compromise may be the
mode of presentation in 18% of cases [38].
Few patients with UTC present at an early
stage of disease, and in most cases this is where
small foci of UTC is discovered within a larger
differentiated thyroid cancer or found incidentally at thyroidectomy performed for alternate
indications [28, 41, 42]. Only 8% of patients with

125
POORLY DIFFERENTIATED AND UNDIFFERENTIATED THYROID CANCER
anaplastic carcinoma in the SEER database had
disease confined to the thyroid gland at presentation [25]. Local invasion beyond the thyroid
capsule is seen in greater than 82% of cases,
involving surrounding structures including
overlying strap muscles, the trachea and larynx,
esophagus, common carotid artery, adjacent
nerves, great vessels of the superior mediastinum, and overlying skin [22, 37–39, 41]. A study
of adjacent structures involved by UTC found
recurrent laryngeal nerve involvement in 59%,
trachea or larynx in 50%, esophagus in 23%,
carotid artery in 16%, and skin in 7% [39].
Direct invasion ofstructures within the superior
mediastinum can produce superior vena cava
syndrome in a small number of cases (Fig. 9.2)
[28, 37, 40]. Metastatic involvement of regional
lymph nodes can be documented in 21–38% of
patients at presentation and is seen in 83% of
cases at autopsy [25, 37, 38]. Hematogenous
dissemination of the tumor to distant sites can
be demonstrated in 43–64% of patients at the
time of initial assessment and is present in 87%
of cases at autopsy [22, 25, 27, 28, 38, 43, 44].
The most common site of metastatic spread is to
the lungs, seen in 75–88% of patients with metastatic disease [27, 28, 37, 44]. Less common sites
of metastases include the boney skeleton, brain,
adrenal glands, and nonregional lymph nodes
[22, 27, 28, 37, 43, 44].
A staging system for UTC was developed by
Aldinger at the MD Anderson Cancer Center in a
study of 84 patients [40]. In this study, it was
found that patients with UTC confined to the
thyroid (stage I) had a favorable prognosis in
comparison to patients with extracapsular invasion or metastatic spread. The majority of patients
with UTC fall into stages III and IV at presentation. Within the TNM classification of thyroid
cancers of the American Joint Committee on Cancer, all anaplastic thyroid cancers are designated
as T4, stage IV disease due to the poor prognosis
of patients with this malignancy [45].
Pathology
UTC present as large, bulky masses arising from
the thyroid gland. Macroscopically, these
tumors have a pale, white, or tan appearance
on sectioning and are firm or hard on palpation
(Fig. 9.3) [46–48]. Areas of hemorrhage, necrosis, and cystic degeneration within the tumor
substance are frequently apparent and the
tumor may also contain regions of calcification
[46, 48]. The tumor commonly displays indistinct margins with invasion into the adjacent
residual thyroid parenchyma, which may
Fig. 9.2. Computed tomography of the thorax of a patient
with undifferentiated thyroid cancer presenting with superior
vena cava syndrome. Invasion and tumor extension within the
right brachiocephalic vein and superior vena cava toward the
right atrium is demonstrated (large arrow). A pulmonary
metastasis is also present (small arrow).
Fig. 9.3. Postresection specimen showing replacement of the
left lobe of the thyroid by undifferentiated thyroid cancer. The
specimen has been sectioned to demonstrate a bulky pale
tumor mass infiltrating the substance of the thyroid gland
with areas of necrosis and hemorrhage. The mass was resected
in continuity with the overlying strap muscles which were
invaded by the tumor (seen to the left of the specimen).

126
ENDOCRINE SURGERY
appear normal or contain evidence of preexisting nodular disease [47]. Extracapsular invasion
of the tumor into surrounding structures in also
commonly observed.
The histological appearance of UTC varies
considerably among cases, and criteria for histological diagnosis have been defined by the
World Health Organization [1, 49]. Three histological patterns are commonly identified: giant
cell, spindle cell, and squamoid cell types
(Fig. 9.4) [46–48]. In the giant cell form, large
rounded neoplastic cells are seen with abundant
eosinophilic cytoplasm, which display bizarre
arrangements of hyperchromatic nuclei or be
multinucleated. In the cases where spindle cells
predominate, elongated fusiform cells with
hyperchromatic nuclei form fascicles, often
with a dense collagenous stroma, and the
appearance can resemble that of sarcoma. Squamoid cellular patterns are seen less commonly
than giant and spindle cell forms, and display
flattened cells with abundant eosinophilic cytoplasm that form tumor nests and islands that
resemble squamous carcinoma. It is rare for
one pattern to predominate within a tumor,
with most cases of UTC containing regions of
varying histological appearance. In all forms,
tumor cells have a high mitotic rate and frequent mitoses are demonstrated within sections. Large multinucleated cells resembling
osteoclasts may also be seen scattered in
some tumors [47]. Areas of necrosis and
hemorrhage within the tumor substance are
common, and there is frequently an inflammatory cell infiltrate within the stroma. In all
cases, UTC displays a distinct propensity for
metastasis, with areas of invasion into vascular
structures and lymphatic channels routinely
identified in specimens. Histological variants
of UTC have also been described and display
similarly aggressive tumor behavior and poor
prognosis. In the paucicellular variant of spindle cell UTC, prominent fibrosis is seen with
few atypical spindle-shaped cells seen within a
dense collagenous stroma with scattered
inflammatory cells [47, 50]. This lack of cellularity makes diagnosis by fine needle aspiration
(FNA) difficult, and the histological appearance
can closely resemble Riedel’s thyroiditis [50].
An angiomatoid variant of UTC has also been
reported and occurs very rarely, with histological features similar to angiosarcoma but with
a
b
c
Fig. 9.4. (A) Photomicrograph of undifferentiated thyroid
cancer of giant cell type. Large poorly cohesive cells with
pleomorphic nuclei are seen in a haphazard arrangement.
Areas of hemorrhage and necrosis are prominent. Mitotic
figures and multinucleated giant cells are shown (arrow)
(20 magnification). (B) Undifferentiated thyroid cancer
with spindle cell growth pattern. Elongated fusiform cells
are haphazardly arranged in fascicles with a collagenous
stroma. Cells demonstrate hyperchromatic pleomorphic
nuclei (20 magnification). (C) Undifferentiated thyroid
cancer with invasion into adjacent strap muscle (arrows)
(20 magnification).

127
POORLY DIFFERENTIATED AND UNDIFFERENTIATED THYROID CANCER
immunohistochemical staining consistent with
a thyroid follicular cell origin [51].
UTC can closely resemble lymphoma, poorly
differentiated medullary carcinoma, sarcoma,
and some metastatic lesions to the thyroid both
clinically and in histologic appearance. These
malignancies must be differentiated from UTC
as their treatment and prognosis are very different. Primary lymphoma of the thyroid shows a
complete response to external beam radiotherapy in 88% of cases, and combined modality
treatment with radiotherapy and chemotherapy
has resulted in 5-year survival rates of 70%
[52–54]. Medullary thyroid cancer also has
a more favorable prognosis than UTC, with overall 5-year survival rates of 68–86% [23]. As
medullary thyroid cancer can be a manifestation
of the familial syndromes of multiple endocrine
neoplasia (MEN) type 2A and 2B or familial nonMEN medullary thyroid cancer, its differentiation from UTC may be important in the genetic
counseling of siblings and offspring.
Immunohistochemistry is a useful adjunct to
histology in this regard and shows a characteristic
staining pattern. UTC contains few if any cells
that stain positively for thyroglobulin unlike
more differentiated forms of thyroid cancer.
Stains for keratin and vimentin are positive in
up to 80 and 93% of cases, respectively, and confirm an epithelial origin of the tumor [27, 55]. The
absence of staining for calcitonin and chromogranin differentiate UTC from medullary thyroid
cancer, and the absence of leukocyte markers
differentiates UTC from lymphoma [56].
Histological examination of the remnant
thyroid tissue adjacent to the tumor reveals
associated pathology in many cases. Benign
multinodular disease can be identified in the
adjacent thyroid remnant in 20% of resected
specimens [22]. UTC can be seen in close association with a focus of differentiated papillary or
follicular carcinoma in 23–89% of cases, and
these lesions are more frequently papillary
than follicular in nature [7, 22, 27, 37, 40, 43,
57–59]. The presence of such lesions in close
proximity to UTC lends support to the suggestion that many cases of UTC arise by anaplastic
transformation from preexisting foci of differentiated thyroid cancer [60]. Further evidence
for this lies in the fact that 16–21% of patients
with UTC have a prior history of differentiated
thyroid cancer [27, 28, 40, 41]. Studies of the
genetic material of anaplastic cancer cells and
those of the associated differentiated carcinoma
show similarities in aneuploidy, candidate gene
mutations and chromosomal losses and banding patterns that suggest that transformation
has occurred [61–64]. Anaplastic transformation of WDTC to UTC is of clinical importance
as it supports an aggressive approach to the
surgical resection of thyroid lesions suspicious
for malignancy in an attempt to reduce the risk
of developing an aggressive cancer within a preexisting low-risk lesion.
The molecular genetics of UTC has been studied to further define the pathogenesis of these
cancers. Somatic mutations of the tumor suppressor gene p53 are seen in 32–88% of UTC
and yet are uncommon in differentiated thyroid
cancer, and this may play a role in the transformation of these tumors as a late step in their
dedifferentiation [18, 38, 65–70] Mutations of
BRAF, RAS, overexpressed in anaplastic thyroid
carcinoma-1 (OEATC-1); bcl-2 and Nm23 genes
have also been demonstrated in UTC [18, 61, 67,
71–73]. Expression of B-catenin and E-cadherin,
transmembrane glycoproteins involved in intercellular adhesion, is decreased in UTC compared
to differentiated cancers [74]. Chromosomal
abnormalities are seen with increasing frequency
in the progression from differentiated to UTCs,
and tissue microarray analysis of a panel of seven
genes involved in cell growth signaling showed
that a number of genetic mutations are involved
in this process [17, 18, 75]. It is likely that a
number of sequential gene mutationsand genetic
events are involved in the pathogenesis of UTC.
Assessment and Evaluation
The presence of a rapidly enlarging neck mass
arising from the thyroid confirmed on physical
examination should suggest the possibility of
UTC, particularly in the elderly. The diagnosis
in most cases can be made on FNA biopsy of the
neck mass. Careful examination of aspirates by
an experienced cytologist can correctly diagnose UTC in 84–90% of cases [76]. The finding
of tumor giant cells, marked cellular pleomorphism and atypia, frequent mitoses, and
spindle-shaped cells is characteristic [48, 76,
77]. The accuracy of FNA can be limited by the
presence of extensive tumor fibrosis, necrosis or
hemorrhage, hypocellularity of malignant cells,
marked leukocyte infiltration, and the presence

128
ENDOCRINE SURGERY
of differing degrees of differentiation within the
lesion [76]. Formal surgical biopsy of the thyroid is occasionally required where FNA is not
diagnostic.
Imaging has an important role in the evaluation of patients with UTC. Cross-sectional imaging of the neck and mediastinum using
computed tomography (CT) can correctly
define the extent of invasion into adjacent structures such as the trachea, esophagus, and carotid sheath in a high proportion of cases, and
can assess the extent to which invasion or extension of the tumor into the superior mediastinum and its contents has occurred (Fig. 9.5)
a
[78]. UTC are seen as large masses arising
from the thyroid, with low attenuation and
poorly defined margins on CT. Areas of dense
calcification and necrosis are commonly seen
within the tumor mass [78]. Magnetic resonance
imaging has also been used in the assessment of
local invasion with similar accuracy [79]. Correctly defining the extent of extrathyroidal invasion in the neck is invaluable in the preoperative
assessment of the surgical resectability of the
tumor [78]. Imaging of the chest by CT or
plain radiographs should also be performed as
a staging investigation, as patients with metastatic disease will have pulmonary lesions in
more than 85% of cases (Fig. 9.6) [27, 44]. Positron emission tomography using 18-Fluorodeoxyglucose has also been used to assess the
presence and extent of disseminated metastatic
disease, and should be considered in the evaluation of UTC [80].
Fiber-optic examination of the larynx and
upper airway should be performed to assess
vocal cord function and to look for the presence
of external invasion of the airway by tumor.
Indirect laryngoscopy reveals vocal cord paresis
consistent with involvement of the recurrent
laryngeal nerve in 25% of cases [37, 38].
b
Fig. 9.5. (A) Cross-sectional computed tomography appear-
ance of undifferentiated thyroid cancer demonstrating a diffusely invasive large tumor mass arising within the right lobe of
the thyroid compressing the airway. Extracapsular invasion
involving the adjacent trachea and esophagus and enlarged
cervical lymph nodes (arrow) are shown. (B) Coronal sections
demonstrating tumor invasion into the right side of the tracheal wall (arrow) by undifferentiated thyroid cancer. A focus of
calcification is seen within the tumor.
Fig. 9.6. Computed tomography of the thorax of a patient
with undifferentiated thyroid cancer demonstrating a 2.5-cm
pulmonary metastasis posteriorly within the lower lobe of the
left lung (arrow). A smaller metastasis within the posterior right
lower lobe is also seen.

129
POORLY DIFFERENTIATED AND UNDIFFERENTIATED THYROID CANCER
Management Strategies
The therapeutic options available in the management of UTC include surgical resection and
external beam radiotherapy to remove or control local disease within the neck, and systemic
therapy with chemotherapy given to enhance
the effect of radiotherapy and to control disseminated metastatic disease. UTC presents at an
advanced stage with aggressive local invasion or
distal metastatic disease present in most
patients, and curative resection is possible in
only a small proportion [22]. In most cases,
the aims of treatment are to control the effects
of local tumor growth in the neck, to palliate
symptoms of local and disseminated disease,
and to improve the quality of life when possible.
Modern strategies in managing these malignancies frequently employ a combination of treatment modalities to achieve these aims. Unlike
differentiated forms of thyroid cancer, UTC
does not take up radioactive iodine, and therefore systemic therapy with this modality is of no
clinical benefit. Treatment protocols frequently
need to take into consideration the advanced
age and poor performance status of many
patients with this malignancy.
A review of the therapeutic options available
in the management of UTC needs to take into
account the different modes of presentation of
this disease. UTC tends to present with complications of local growth and invasion (including
airway compromise), with complications of disseminated disease, or occasionally as an incidental finding at an early stage. The approach to
management must be modified as dictated by
the mode of presentation of the patient and the
clinical findings after appropriate assessment
and investigation.
Clinical Scenario 1: Incidental
Finding of UTC
Patients with UTC confined to the thyroid gland
represent only 8% of cases, and their prognosis
is the most favorable with long-term survival
possible after complete resection of the tumor
[25]. Many of the cases in this subgroup represent foci of UTC found within larger more
differentiated thyroid cancers, or discovered
incidentally within the resection specimen at
thyroidectomy for another indication [42]. In
patients where UTC is found as a small focus
without extrathyroidal invasion, a 1-year survival rate of 73% and a 2-year survival rate of 46%
have been reported [59]. In this way, although
the prognosis of patients with a small focus of
UTC completely resected compares favorably to
larger clinically apparent anaplastic cancers,
additional treatment with external beam radiotherapy and chemotherapy have been recommended due to the risk of recurrent and disseminated disease.
Much of the favorable prognosis associated
with small and incidentally found UTC lies in
their complete resection prior to progression of
disease beyond the thyroid. The majority of
patients with UTC unfortunately present with
advanced disease where complete resection of
the tumor with a curative intent is not possible
[22, 27]. Complete surgical resection of UTC
confined to the thyroid offers the greatest
chance of long-term survival, and has been
combined with postoperative chemoradiotherapy to achieve 5-year survival rates of 50–60%
[37, 43]. A Japanese study of 11 patients with a
small focus of UTC found incidentally, the mortality was 36% and in three patients death was
due to complications of locoregional recurrence
in the neck [42]. Adjuvant treatment with external beam radiotherapy has been recommended
to reduce this risk [28, 42]. In a study of 67
patients with UTC from the Massachusetts Hospital, radiotherapy was given after surgical
resection in all cases and was associated with
an improvement in survival at higher doses
(>45 Gy) [28]. Complete surgical resection was
achieved in 18% of cases and was associated
with a significantly higher survival than incompletely resected tumors, with 83% of these
patients surviving beyond 3 years. Radiotherapy combined with surgical resection has been
associated with an improved survival in patients
studied in the SEER database [25]. Radiotherapy was, however, not associated with a reduced
risk of local recurrence in a large study of 134
patients with UTC from the Mayo Clinic [22]. In
this study, surgical resection was performed in
72% of cases, with complete resection achieved
in 30%. Most patients received radiotherapy
postoperatively. Patients treated surgically had
a longer duration of survival than those managed nonoperatively, but no improvement in survival or local recurrence in the neck was seen
after complete resection when compared with
Соседние файлы в папке Библиотека им академика М.И. Перельмана
